A dual gene-signature framework for glioma survival prediction with multi-cohort validation
Open Access
- 12 May 2026
- journal article
- Published by Elsevier in Immunobiology
- Vol. 231 (3) , 153187
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- GliomaNature Reviews Disease Primers, 2024
- Image-based deep learning identifies glioblastoma risk groups with genomic and transcriptomic heterogeneity: a multi-center studyEuropean Radiology, 2022
- Deep learning features from diffusion tensor imaging improve glioma stratification and identify risk groups with distinct molecular pathway activitiesEBioMedicine, 2021
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summaryNeuro-Oncology, 2021
- A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium studyNeuro-Oncology, 2021
- An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma MultiformeMolecular Neurobiology, 2017
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse GliomaCell, 2016
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- A review of feature selection techniques in bioinformaticsBioinformatics, 2007
- Pitfalls in the Use of DNA Microarray Data for Diagnostic and Prognostic ClassificationJNCI: Journal of the National Cancer Institute, 2003